TPE vs. INUSpheresis®: Why the Premium Choice in Advanced Blood Purification Delivers Superior Results for Detox, Longevity & Chronic Conditions
Why INUSpheresis® Is the Premium Choice (Compared with standard U.S. Therapeutic Plasma Exchange / TPE)?
At ZIV Medical Concierge, we connect patients across North and South America with the world’s most advanced regenerative and detox therapies. One of the most frequent questions we receive is: “How does INUSpheresis® compare to standard Therapeutic Plasma Exchange (TPE) available in the U.S.?”
The short answer: While both are forms of apheresis, they differ dramatically in mechanism, precision, safety profile, and clinical outcomes — making INUSpheresis® the clear premium choice for patients seeking deep, gentle, and effective blood purification for chronic inflammation, environmental toxin overload, Long COVID, and longevity optimization.
Understanding the Two Approaches:
Standard U.S. Therapeutic Plasma Exchange (TPE) is a well-established procedure in which a patient’s plasma — the liquid portion of blood containing proteins, antibodies, toxins, and inflammatory mediators — is removed and discarded. It is then replaced with donor plasma or albumin solutions to maintain blood volume.
INUSpheresis® is a highly refined form of double-filtration plasmapheresis (DFPP). Using two specialized membrane filters in a closed-loop system, it selectively captures unwanted large molecules and toxins while returning the patient’s own purified plasma. No replacement fluids are needed.
Here is a clear comparison of the major differences:
1. Plasma Handling: Removal & Replacement vs. Closed-Loop Purification
TPE: Removes plasma entirely and replaces it with donor fluid or albumin.
INUSpheresis®: Purifies and returns your own plasma — closed loop.
This closed-loop design eliminates the need for foreign fluids, reducing risks of allergic reactions and volume shifts while preserving the body’s natural balance.
2. Protein Preservation: Significant Loss vs. Selective Sparing
TPE: Removes 63–70% of valuable proteins.
INUSpheresis®: Preserves ~75% albumin and ~59% globulins.
A 2025 ex-vivo and in-vivo study on double-filtration plasmapheresis (the exact technology behind INUSpheresis®) confirmed a significant sparing effect on albumin, with net albumin loss substantially lower than globulin and fibrinogen loss. This selectivity protects essential proteins critical for immunity, oncotic pressure, and overall physiological stability.
3. Spectrum of Toxins Removed: Limited vs. Broad-Spectrum
TPE: Mainly large proteins and some lipids.
INUSpheresis®: Broader spectrum — microplastics, heavy metals, PFAS, cytokines, environmental toxins, and more.
Peer-reviewed research has documented the removal of micro- and nanoplastics, heavy metals, pesticides, solvents, and persistent organic pollutants in the eluate from INUSpheresis® treatments. One study using field-emission scanning electron microscopy confirmed the presence of diverse particulate matter in the filtered waste — substances that standard TPE does not target as effectively.
4. Replacement Fluid Needed?
TPE: Yes (risk of reactions & volume shifts).
INUSpheresis®: No.
Avoiding replacement fluids is one of the biggest advantages. TPE’s reliance on albumin or donor plasma introduces risks of hypersensitivity, infection transmission (however rare), and hemodynamic instability. INUSpheresis® sidesteps these entirely.
5. Tissue Detox Effect: Blood-Only vs. Deeper Mobilization
TPE: Primarily blood only.
INUSpheresis®: Deeper mobilization from tissues & organs.
Because INUSpheresis® processes larger volumes of plasma with minimal disruption, it promotes redistribution and clearance of toxins stored in tissues — an effect supported by pharmacokinetic analyses of environmental pollutants in DFPP patients.
6. Typical Side Effects & Patient Experience
TPE: 8–15% of sessions (hypotension, allergic reactions) — often more disruptive.
INUSpheresis®: ~0.7% (mostly mild & transient) — gentler, faster, more comfortable.
Large registries of TPE report complication rates ranging from 7–37% depending on the study population, with common issues including hypotension, urticaria, and electrolyte shifts. In contrast, internal data from INUS Medical Center (over 50,000 treatments) and published DFPP studies show an exceptionally low adverse-event rate of approximately 0.7%, with patients consistently describing the experience as far more tolerable.
INUSpheresis® Is the Obvious Premium Choice!
For acute, life-threatening conditions (e.g., certain autoimmune crises), TPE remains a valuable tool in hospital settings. But for chronic wellness, toxin detoxification, Long COVID recovery, and longevity, INUSpheresis® stands in a class of its own:
Returns your own plasma (no foreign proteins)
Preserves essential proteins while removing harmful ones
Targets the full spectrum of modern environmental toxins
Requires no replacement fluids
Offers deeper tissue-level detox
Delivers superior comfort and safety
Leading clinicians and researchers associated with INUSpheresis® — including those at INUS Medical Center and collaborating institutions — emphasize its selectivity and tolerability as game-changers for patients who need repeated treatments without the cumulative burden of standard TPE.
Cost Comparison: Standard TPE vs. ZIV INUSpheresis® Packages
While both therapies involve blood purification, the total investment and value delivered differ significantly.
Standard U.S. TPE (Next Health Model): Typical Protocol 5–10 sessions over 4 weeks. Total Program Cost $50,000 – $100,000+
ZIV Packages with our partner clinics: Price per Core Treatment 2 INUSpheresis® sessions starting at $12,500. Contact ZIV Advisor for details on treatment packages and costs.
Major Cost Driver with Standard U.S. TPE: significant amounts of Human Serum Albumin to replace the removed plasma. INUSpheresis®: No replacement fluids required!
Ready to experience the difference?
ZIV Medical Concierge provides priority access to certified INUSpheresis® clinics in Europe and the UAE, with Personalized care engineered for optimal longevity.
Contact us today for a confidential consultation and discover whether INUSpheresis® is the right next step in your wellness journey.
References:
Troia R, et al. “Selective Removal of Plasma Proteins by Double-Filtration Plasmapheresis in Canine Blood: An Ex Vivo Study…” Veterinary Sciences, 2025.
Scholkmann F, et al. “Particles in the Eluate from Double Filtration Plasmapheresis…” Compounds, 2022.
Castillo-Aleman YM, et al. “Double Filtration Plasmapheresis for Environmental Toxin Removal…” Journal of Clinical Apheresis, 2025.
Bornstein SR, et al. “Therapeutic apheresis: A promising method to remove microplastics?” PMC, 2025.
INUS Medical Center internal data (SOP protocol, >50,000 treatments).
Multiple peer-reviewed reviews on TPE complications (e.g., Lu J et al., PMC, 2019; Afzali M et al., 2020).
Global Apheresis clinical comparison of DFPP vs. TPE.
Disclaimer: This blog post is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult with your physician before considering any therapy, including INUSpheresis®.
